Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 5/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | SAT1 | P21673 | 3/20 | 0.39 |
| ▸ | RELA | Q04206 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23965073 | 0.98 | CYP2C19 (0.50) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL918515 | 0.95 | CYP2C19 (0.52) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| Ammonia Solution, Strong SCHEMBL18796810 | 0.93 | CYP2C19 (0.50) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL1979880 | 0.85 | — | — | |
| SCHEMBL7108955 | 0.85 | APP (0.50) | CYP2C19CYP1A2MEN1KMT2ATSHR | |
| SCHEMBL15305904 | 0.84 | PAOX (0.52) | CYP2C19CYP1A2TSHREPHX2APP | |
| SCHEMBL21518352 | 0.84 | ALDH1A1 (0.59) | TSHREPHX2RELAALDH1A1 | |
| SCHEMBL21518429 | 0.84 | TSHR (0.52) | MEN1KMT2ATSHREPHX2APP | |
| SCHEMBL5889198 | 0.83 | CYP2C19 (0.42) | CYP2C19CYP1A2MEN1GLAKMT2A | |
| SCHEMBL22800815 | 0.82 | EPHX2 (0.57) | TSHREPHX2RELAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0626374-B1 | A diaminostilbene series compound and a method for forming an image using the same | FUJI PHOTO FILM CO LTD (JP) | 2002-08-07 | — | — | EP | claimed |
| US-5395742-A | IMAGEWISE EXPOSURE OF A PHOTOGRAPHIC MATERIAL TO LIGHT | FUJI PHOTO FILM CO., LTD. (JP) | 1995-03-07 | — | — | US | claimed |
| EP-0626374-A2 | A diaminostilbene series compound and a method for forming an image using the same | FUJI PHOTO FILM CO., LTD. (JP) | 1994-11-30 | — | — | EP | claimed |
| US-5106990-A | Absorb infrared radiation, discolor during photographic development | FUJI PHOTO FILM CO., LTD. (JP) | 1992-04-21 | — | — | US | claimed |
| EP-4107198-B1 | POLYISOCYANATE PREPARATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2024-03-13 | — | — | EP | disclosed |
| EP-3560975-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES AND ANTIOXIDANTS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-12-06 | — | — | EP | disclosed |
| US-20230382857-A1 | HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS | CHILDREN'S NATIONAL MEDICAL CENTER (US) | 2023-11-30 | — | — | US | disclosed |
| EP-3724251-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-11-22 | — | — | EP | disclosed |
| US-11787764-B2 | Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems | CHILDREN'S NATIONAL MEDICAL CENTER (US) | 2023-10-17 | — | — | US | disclosed |
| EP-3851472-B1 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-06-07 | — | — | EP | disclosed |
| US-20230080775-A1 | POLYISOCYANATE PREPARATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2023-03-16 | — | — | US | disclosed |
| EP-4107198-A1 | POLYISOCYANATE PREPARATIONS | Covestro Deutschland AG (DE) | 2022-12-28 | — | — | EP | disclosed |
| US-5223382-A | Containing cyanine dye with chromene ring; quickly decolored during development, excellent sharpness, less residual color | FUJI PHOTO FILM CO., LTD. (JP) | 1993-06-29 | — | — | US | disclosed |
| US-5162195-A | Scanning exposure to three wavelengths, indole cyanine dye sensitizer | FUJI PHOTO FILM CO., LTD. (JP) | 1992-11-10 | — | — | US | disclosed |
| US-5106990-A | Absorb infrared radiation, discolor during photographic development | FUJI PHOTO FILM CO., LTD. (JP) | 1992-04-21 | — | — | US | disclosed |
| US-5077186-A | Indole dyes with at least three acid groups; antihalants | MITSUBISHI PAPER MILLS LIMITED (JP) | 1991-12-31 | — | — | US | disclosed |
| EP-0445627-A1 | Silver halide photographic light-sensitive materials | FUJI PHOTO FILM CO., LTD. (JP) | 1991-09-11 | — | — | EP | disclosed |
| EP-0430244-A1 | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1991-06-05 | — | — | EP | disclosed |
| EP-0383265-A2 | Method for forming color image | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-22 | — | — | EP | disclosed |
| US-4756993-A | Light scattering layer comprises inorganic fine powder and binder or light absorbing layer comprising near infrared absorbing dye and binder | FUJI PHOTO FILM CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787764-B2 | Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems | CD68, PAX2, PYGL | CYP2C19 1127/4885CYP1A2 246/4885MEN1 512/4885 |
| US-20230382857-A1 | HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS | CD68, HCCS, NR1H4 | CYP2C19 1243/4885CYP1A2 305/4885MEN1 572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.